MEASUREMENT OF THE CHEMOTACTIC COMPLEMENT FRAGMENT C5A IN RHEUMATOID SYNOVIAL-FLUIDS BY RADIOIMMUNOASSAY - ROLE OF C5A IN THE ACUTE INFLAMMATORY PHASE

被引:136
作者
JOSE, PJ
MOSS, IK
MAINI, RN
WILLIAMS, TJ
机构
[1] MRC,CLIN RES BRANCH,VASC BIOL SECT,HARROW HA1 3UJ,MIDDX,ENGLAND
[2] CHARING CROSS & WESTMINSTER MED SCH,DEPT CLIN RES,LONDON W6,ENGLAND
[3] CHARING CROSS & WESTMINSTER MED SCH,DEPT IMMUNOL RHEUMAT DIS,LONDON W6,ENGLAND
关键词
D O I
10.1136/ard.49.10.747
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence suggests that complement is activated in rheumatoid joints. A sensitive radioimmunoassay for the activation fragment of C5, C5a, which is a potent chemoattractant for neutrophils, was therefore developed. A mean CSa concentration in 22 rheumatoid joint fluids of about 2-5xlO-9 mol/l was found. This concentration of C5a is sufficient to induce two of the characteristic features of the acute inflammatory phases of rheumatoid arthritis: neutrophil accumulation and microvascular plasma protein leakage. In animal models it has been shown that C5a is a potent inducer of inflammatory oedema by a neutrophil dependent mechanism. A striking feature of the acute inflammatory phases of rheumatoid arthritis is the appearance ofhigh numbers of neutrophils in the synovial fluid. It is suggested that CSa might have a role in mediating neutrophil accumulation and, as a consequence, may be important in acute joint swelling and pain.
引用
收藏
页码:747 / 752
页数:6
相关论文
共 42 条
[1]   CHEMOTACTIC FACTORS OF INFLAMMATION [J].
BECKER, EL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1983, 4 (05) :223-225
[2]   MEASUREMENT OF THE COMPLEMENT C-3 BREAKDOWN PRODUCT C3D BY ROCKET IMMUNOELECTROPHORESIS [J].
BOURKE, BE ;
MOSS, IK ;
MAINI, RN .
JOURNAL OF IMMUNOLOGICAL METHODS, 1982, 48 (01) :97-108
[3]   DEMONSTRATION OF SPECIFIC C5A RECEPTOR ON INTACT HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
CHENOWETH, DE ;
HUGLI, TE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (08) :3943-3947
[4]  
CHENOWETH DE, 1981, NEW ENGL J MED, V304, P493
[5]  
DAMERAU B, 1976, N-S ARCH PHARMACOL, V255, P237
[6]  
ELGHOBAREY AF, 1980, J RHEUMATOL, V7, P453
[7]  
FERNANDEZ HN, 1978, J BIOL CHEM, V253, P6955
[8]   CLINICAL APPLICATIONS OF COMPLEMENT MEASUREMENTS IN RHEUMATIC DISEASES [J].
GOLDSTEIN, IM .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1975, 269 (02) :172-182
[9]   CHARACTERIZATION AND FUNCTIONAL-STUDIES OF RHEUMATOID SYNOVIAL MAST-CELLS - ACTIVATION BY SECRETAGOGUES, ANTI-IGE, AND A HISTAMINE-RELEASING LYMPHOKINE [J].
GRUBER, B ;
POZNANSKY, M ;
BOSS, E ;
PARTIN, J ;
GOREVIC, P ;
KAPLAN, AP .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :944-955
[10]  
HEDBERG H, 1963, Acta Rheumatol Scand, V9, P165